In a small trial, nearly half of pancreatic cancer patients who received an mRNA vaccine for the disease had no relapse three years later.

Platform fosters collegial interactions among scientists, but potentially limits interactions beyond the academic community

In this meta-analysis, the most common actionable and undruggable mutations in resected intrahepatic cholangiocarcinoma are determined. Among the heterogen